These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20439144)

  • 21. Isolation and identification of five impurities of ALB 109564(a) drug substance.
    Milanowski DJ; Keilman J; Guo C; Mocek U
    J Pharm Biomed Anal; 2011 May; 55(2):366-72. PubMed ID: 21353428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
    Eckers C; Laures AM; Giles K; Major H; Pringle S
    Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of impurities in streptomycin and dihydrostreptomycin by hydrophilic interaction chromatography/electrospray ionization quadrupole ion trap/time-of-flight mass spectrometry.
    Kawano S
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):907-14. PubMed ID: 19224534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of impurities in docetaxel.
    Vasu Dev R; Moses Babu J; Vyas K; Sai Ram P; Ramachandra P; Sekhar NM; Mohan Reddy DN; Srinivasa Rao N
    J Pharm Biomed Anal; 2006 Feb; 40(3):614-22. PubMed ID: 16330175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high-performance liquid chromatography combined with mass spectrometry.
    Xu H; Wang D; Sun C; Pan Y; Zhou M
    J Pharm Biomed Anal; 2007 Jun; 44(2):414-20. PubMed ID: 17420108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
    McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
    J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural studies of impurities of risperidone by hyphenated techniques.
    Sattanathan P; Babu JM; Vyas K; Reddy RB; Rajan ST; Sudhakar P
    J Pharm Biomed Anal; 2006 Feb; 40(3):598-604. PubMed ID: 16316737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of a 2:1 hydrochlorothiazide-formaldehyde adduct impurity in hydrochlorothiazide drug substance by preparative chromatography and characterization by electrospray ionization LC-MS.
    Franolic JD; Lehr GJ; Barry TL; Petzinger G
    J Pharm Biomed Anal; 2001 Nov; 26(4):651-63. PubMed ID: 11516917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and structural characterization of eight impurities in aztreonam.
    Li Y; Yuan M; Ding D; Jiang X; Ye Q; Guo F
    J Pharm Biomed Anal; 2022 Feb; 210():114587. PubMed ID: 35026590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photochemical stability of 4'-azido-2'-deoxy-2'-methylcytidine hydrochloride: structural elucidation of major degradation products by LC-MS and NMR analysis.
    Huybrechts T; Hermans M; Van Hoof B; Winderickx G; De Neef C; Hostyn S; Vrielynck S; Vermeulen W
    J Pharm Biomed Anal; 2012 Nov; 70():231-44. PubMed ID: 22841557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and identification of process impurities in trimethoprim drug substance by high-performance liquid chromatography, atmospheric pressure chemical ionization liquid chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy.
    Lehr GJ; Barry TL; Petzinger G; Hanna GM; Zito SW
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):373-89. PubMed ID: 10704103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.